Evidence map›Paper›PMID 34635085›Full record

ArticleBMC public health2021

COVID-19 hotspots through clusters analysis in France (may-October 2020): where should we track the virus to mitigate the spread?

Guillaume Spaccaferri, Clémentine Calba, Pascal Vilain, Loïc Garras, Cécile Durand, Corinne Pilorget, Nahida Atiki, Pascale Bernillon, Laëtitia Bosc, Erica Fougère and 12 more

Abstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Guillaume SpaccaferriSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France. guillaume.spaccaferri@santepubliquefrance.fr.ORCID 0000-0003-4068-0672
Clémentine CalbaSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Pascal VilainSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Loïc GarrasSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Cécile DurandSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Corinne PilorgetSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Nahida AtikiSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Pascale BernillonSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Laëtitia BoscSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Erica FougèreSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Jean-Baptiste HanonSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Valérie HenrySanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Caroline Huchet-KervellaSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Mélanie MartelSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Valérie PontièsSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Damien MoulySanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Enguerrand Rolland du RoscoatSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Stéphane Le VuSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Jean-Claude DesenclosSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Anne LaporteSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.
Regional MONIC group
Patrick RollandSanté publique France, 12 Rue du Val d'Osne, 94410, Saint-Maurice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn France, the lifting of the lockdown implemented to control the COVID-19 first wave in 2020 was followed by a reinforced contact-tracing (CT) strategy for the early detection of cases and transmission chains. We developed a reporting system of clusters defined as at least three COVID-19 cases, within seven days and belonging to the same community or having participated in the same gathering, whether they know each other or not. The aim of this study was to describe the typology and criticality of clusters reported between the two lockdowns in France to guide future action prioritisation.

methodsIn this study we describe the typology and criticality of COVID-19 clusters between the two lockdowns implemented in France (between May and end of October 2020). Clusters were registered in a national database named "MONIC" (MONItoring des Clusters), established in May 2020. This surveillance system identified the most affected communities in a timely manner. A level of criticality was defined for each cluster to take into consideration the risk of spreading within and outside the community of occurrence, and the health impact within the community. We compared the level of criticality according to the type of community in which the cluster occurred using Pearson's chi-square tests.

resultsA total of 7236 clusters were reported over the study period, particularly in occupational environment (25.1%, n = 1813), elderly care structures (21.9%, n = 1586), and educational establishments (15.9%, n = 1154). We show a shift over time of the most affected communities in terms of number of clusters. Clusters reported in occupational environment and the personal sphere had increased during summer while clusters reported in educational environment increased after the start of the school year. This trend mirrors change of transmission pattern overtime according to social contacts. Among all reported clusters, 43.1% had a high level of criticality with significant differences between communities (p < 0.0001). A majority of clusters had a high level of criticality in elderly care structures (82.2%), in disability care centres (56.6%), and health care facilities (51.7%).

conclusionThese results highlight the importance of targeting public health action based on timely sustained investigations, testing capacity and targeted awareness campaigns. The emergence of new SARS-CoV-2 variants strengthen these public health recommendations and the need for rapid and prioritise vaccination campaigns.

Indexed as

Contact TracingCOVID-19Communicable Disease ControlFranceHumansSARS-CoV-2ClustersCOVID-19CriticalityDescriptive analysisHotspotsPublic health

Identifiers

PMID34635085
PMCPMC8503705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.